The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.
Clinical trial NCT07152340 · RECRUITING
Trial details
- NCT number
- NCT07152340
- Sponsor
- Shanghai Changzheng Hospital
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-10
- Primary completion
- 2027-04-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.